Literature DB >> 31676060

Medical Management of Inflammatory Bowel Disease.

Derrick D Eichele1, Renee Young2.   

Abstract

Inflammatory bowel disease has become a growing concern worldwide. The chronic and progressive nature of inflammatory bowel disease poses significant challenges to the treatment and management of affected patients, straining health care resources. Therapeutic options and optimal management strategies have evolved dramatically. The treat-to-target strategy has shifted focus toward identifiable and attainable treatment targets and with the ability to optimize tight control. Advancements in our understanding of the pathophysiology led to therapeutic mechanisms that have a more narrowed focus toward gut-specific targets, improving safety profiles.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammatory bowel disease; Management; Therapeutic drug monitoring; Treat-to-target strategy; Treatment

Mesh:

Substances:

Year:  2019        PMID: 31676060     DOI: 10.1016/j.suc.2019.08.011

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  5 in total

Review 1.  Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?

Authors:  Vicente Martínez; Amaia Iriondo De-Hond; Francesca Borrelli; Raffaele Capasso; María Dolores Del Castillo; Raquel Abalo
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

2.  Methane Alleviates Inflammation and Apoptosis of Dextran Sulfate Sodium-Induced Inflammatory Bowel Diseases by Inhibiting Toll-Like Receptor 4 (TLR4)/Myeloid Differentiation Factor 88 (MyD88)/Nuclear Translocation of Nuclear Factor-κB (NF-κB) and Endoplasmic Reticulum Stress Pathways in Mice.

Authors:  Naiying Shen; Zhixiang Wang; Cong Wang; Jingyao Zhang; Chang Liu
Journal:  Med Sci Monit       Date:  2020-06-05

Review 3.  Helicobacter bilis Contributes to the Occurrence of Inflammatory Bowel Disease by Inducing Host Immune Disorders.

Authors:  Wei Peng; Xinhua Zhao; Xiaoan Li
Journal:  Biomed Res Int       Date:  2022-08-09       Impact factor: 3.246

4.  Mapping global research trends in stem cell therapy for inflammatory bowel disease: a bibliometric analysis from 1991 to 2019.

Authors:  Yuming Chong; Chang Han; Ji Li; Xiao Long
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

5.  Impact of a nurse navigator on a dedicated inflammatory bowel disease-focused gastroenterology clinic.

Authors:  Parth Maheshwari; Anne Bobb; August Stuart; Shannon Dalessio; Nana Bernasko; Andrew Tinsley; Kofi Clarke; Matthew D Coates; Emmanuelle Williams
Journal:  Ann Gastroenterol       Date:  2021-05-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.